A nurse is providing education to a family of a child who has Kawasaki disease. The caregiver expresses concern about giving the child aspirin. Which of the following statements is the best response by the nurse?

Rationale: A. Aspirin is essential in Kawasaki disease because it reduces inflammation and decreases the risk of coronary artery aneurysms, which are the most serious complication. Although aspirin is generally avoided in children, its therapeutic benefit in controlling vasculitis and platelet aggregation in Kawasaki disease outweighs the potential risk of Reye syndrome. B. Reye syndrome can be life-threatening and is not considered easier to treat. Using fear-based comparisons may increase caregiver anxiety and does not accurately reflect evidence-based recommendations regarding aspirin use in Kawasaki disease. C. This statement is inaccurate because true aspirin (acetylsalicylic acid) is the medication given for Kawasaki disease. Minimizing or denying the risk misinforms caregivers and fails to explain why aspirin is used despite general pediatric caution. D. Some phases of Kawasaki treatment use higher anti-inflammatory doses initially, later moving to lower antiplatelet doses. Risk discussions should be honest and balanced, emphasizing monitoring and medical necessity rather than dismissing the potential for adverse effects.